MRC2 and mesothelioma: Altogether, additional studies will be required to address the sensitivity of mesothelioma cells to anti-uPARAP ADCs with different payloads, also including studies on factors such as the cellular expression of multidrug resistance genes or other cellular properties that might influence the sensitivity patterns.